Randomized controlled study of endoscopic surgery and traditional therapy for nasopharyngeal carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035818

Enrollment

Unknown

Registered

2020-08-17

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Experimental group:Endoscopic surgery

control group:Radiotherapy + chemotherapy

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 20-70 years. 2. There are no restrictions on nationalities and men and women. 3. The patient was confirmed as nasopharyngeal carcinoma by histopathology.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart failure, liver and kidney dysfunction, and systemic infection. 2. Pregnant women and lactation patients. 3. Patients with contraindications. 4. Patients who had received surgery, radiotherapy, chemotherapy, biotherapy, targeted therapy and other anti-tumor treatments before the start of the study. 5. Participants in other clinical trials in the study. 6. Those who do not understand or cooperate with clinical trials.

Design outcomes

Primary

Measure	Time frame
3. 5-year tumor free survival rate ;quality of life;	—

Secondary

Measure	Time frame
recurrence rate;	—

Countries

China

Contacts

Public ContactYongtian Lu

Shenzhen Second People's Hospital

luyongtian@263.net+86 13602666223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026